[
  {
    "ts": null,
    "headline": "Investment Firm Bets Big on ESAB's Welding and Cutting Technology",
    "summary": "ESAB delivers welding, cutting, and digital solutions to industrial clients worldwide, spanning sectors from construction to energy.",
    "url": "https://finnhub.io/api/news?id=c948eb3156e8f6235fd3ff820a8769073dc470d5abff941f378640c9a149ceb0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772210485,
      "headline": "Investment Firm Bets Big on ESAB's Welding and Cutting Technology",
      "id": 139254553,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "ESAB delivers welding, cutting, and digital solutions to industrial clients worldwide, spanning sectors from construction to energy.",
      "url": "https://finnhub.io/api/news?id=c948eb3156e8f6235fd3ff820a8769073dc470d5abff941f378640c9a149ceb0"
    }
  },
  {
    "ts": null,
    "headline": "Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics",
    "summary": "Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced a landmark fulfillment agreement with MWI Animal Health (MWI), part of global healthcare company Cencora, to create the first-ever ultra-low temperature cold chain for veterinary medicine. This comes as Gallant advances toward delivering the potential first-ever FDA-approved off-the-shelf veterinary stem cell therapy, pending conditional approval by the U.S. Food and Drug Admini",
    "url": "https://finnhub.io/api/news?id=f514e8fa43ff48acf0a4d1584c6b966c99cd43b8e526835b11c5a7ed7d39b6c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772206680,
      "headline": "Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics",
      "id": 139250146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced a landmark fulfillment agreement with MWI Animal Health (MWI), part of global healthcare company Cencora, to create the first-ever ultra-low temperature cold chain for veterinary medicine. This comes as Gallant advances toward delivering the potential first-ever FDA-approved off-the-shelf veterinary stem cell therapy, pending conditional approval by the U.S. Food and Drug Admini",
      "url": "https://finnhub.io/api/news?id=f514e8fa43ff48acf0a4d1584c6b966c99cd43b8e526835b11c5a7ed7d39b6c4"
    }
  }
]